Changeflow GovPing Pharma & Drug Safety Pyridine Carboxamide Compounds for Treating Med...
Routine Notice Added Draft

Pyridine Carboxamide Compounds for Treating Medical Conditions

Favicon for changeflow.com ChangeBridge: Patent Apps - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO published patent application US20260092062A1 for pyridine carboxamide compounds and their use in treating medical conditions. The application was filed by inventors Todd Bosanac, Nathan Oliver Fuller, Robert Owen Hughes, Guy Bemis, and Janeta Valentina Popovici Muller on September 26, 2023, and published on April 2, 2026.

What changed

The USPTO published a patent application (US20260092062A1) disclosing pyridine carboxamide compounds, pharmaceutical compositions containing them, and methods of using them to treat medical conditions. The application claims compounds classified under CPC categories including C07D 471/04 and various A61K therapeutic formulations. The inventors are associated with undisclosed pharmaceutical research.

Patent applications are informational filings that establish priority dates and initiate the examination process. No compliance deadlines or regulatory obligations arise from this publication. Companies developing similar compounds should conduct freedom-to-operate analyses and monitor the patent prosecution timeline.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PYRIDINE CARBOXAMIDE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

Application US20260092062A1 Kind: A1 Apr 02, 2026

Inventors

Todd Bosanac, Nathan Oliver Fuller, Robert Owen Hughes, Guy Bemis, Janeta Valentina Popovici Muller

Abstract

The invention provides pyridine carboxamide compounds, pharmaceutical compositions, and their use in treating medical conditions.

CPC Classifications

C07D 471/04 A61K 31/444 A61K 31/4545 A61K 31/4725 A61K 31/506 A61K 31/519 A61K 31/5377 A61K 31/538 C07D 519/00

Filing Date

2023-09-26

Application No.

19113556

View original document →

Named provisions

Pyridine Carboxamide Compounds Pharmaceutical Compositions Medical Treatment Methods

Get daily alerts for ChangeBridge: Patent Apps - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260092062A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Pharmaceutical Compound Patents Medical Treatment Patents
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Healthcare Intellectual Property

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.